Early study success paves way for Photocure's next-gen Cevira cervical precancer treatment
This article was originally published in Scrip
Executive Summary
A next-generation version of Photocure's Cevira photodynamic treatment for precancerous cervical lesions has shown promise in a small feasibility study, setting the scene for results from a bigger Phase II trial later this year.